105544-30-7

Basic information

• Product Name: 5-Bromo-3-nitro-pyridin-2-yloxy)-acetic acid ethyl ester
• Synonyms: 5-Bromo-3-nitro-pyridin-2-yloxy)-acetic acid ethyl ester ;ethyl 2-(5-bromo-3-nitropyridin-2-yloxy)acetate
• CAS NO: 105544-30-7
• Molecular Formula: C₉H₉BrN₂O₅
• Molecular Weight: 305.083
• Mol File: 105544-30-7.mol
• Article Data: 8

Chemical Properties

• Melting Point: 63-64 °C
• Boiling Point: 364.1 °C at 760 mmHg
• Flash Point: 174 °C
• Appearance: /
• Density: 1.625 g/cm³
• Vapor Pressure: 1.72E-05mmHg at 25°C
• Refractive Index: 1.562
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: -3.22±0.32(Predicted)
• CAS DataBase Reference: 5-Bromo-3-nitro-pyridin-2-yloxy)-acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-3-nitro-pyridin-2-yloxy)-acetic acid ethyl ester(105544-30-7)
• EPA Substance Registry System: 5-Bromo-3-nitro-pyridin-2-yloxy)-acetic acid ethyl ester(105544-30-7)

Safety Data

• Hazardous Substances Data: 105544-30-7(Hazardous Substances Data)

Usage

General Description

5-Bromo-3-nitro-pyridin-2-yloxy)-acetic acid ethyl ester is a chemical compound that belongs to the ester class of molecules. It is primarily used in the pharmaceutical industry as an intermediate for the synthesis of various organic compounds. This chemical is known for its unique chemical structure, which includes a pyridine ring with a bromine and nitro group attached to it, as well as an acetic acid ester. The presence of these functional groups makes it useful as a reagent in organic synthesis and drug discovery processes. Additionally, it is important to handle this compound with proper safety measures, as it can be hazardous if not handled according to safety guidelines.

InChI:InChI=1/C9H9BrN2O5/c1-2-16-8(13)5-17-9-7(12(14)15)3-6(10)4-11-9/h3-4H,2,5H2,1H3

Upstream product

• 67443-38-3 5-bromo-2-chloro-3-nitropyridine 
• 623-50-7 ethyl 2-hydroxyacetate 
• 38233-96-4 ethyl 2-hydroxyacetate sodium salt 

Downstream Products

• 946121-78-4 7-bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine 
• 1313441-66-5 7-bromo-1-ethyl-8-phenyl-4H-pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]oxazine 
• 1313485-80-1 (E)-6-bromo-2-hydrazono-7-phenyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine 
• 1313441-65-4 tert-butyl 4-(1-(cyanomethyl)-2-oxo-7-phenyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)benzylcarbamate 
• 1313441-64-3 tert-butyl 4-(2-oxo-7-phenyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)benzylcarbamate 
• 1313441-55-2 7-bromo-1-(difluoromethyl)-8-phenyl-4H-pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]oxazine 
• 1313441-54-1 6-bromo-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-thione 
• 1313441-33-6 6-bromo-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 1198154-03-8 7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 1313441-32-5 ethyl 2-((3-nitro-5-phenylpyridin-2-yl)oxy)acetate 
• 107113-02-0 7-Bromo-3-[1-phenyl-meth-(Z)-ylidene]-1H-pyrido[2,3-b][1,4]oxazin-2-one 
• 105544-36-3 7-bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 

Relevant articles and documents

CHROMENOPYRIMIDINE DERIVATIVES AS PHOSPHATIDYLINSITOL PHOSPHATE KINASE INHIBITORS

The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: where A1, A2, G, R1, R2, R3, R4, and W are described herein.

HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND METHOD USING THE SAME

The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis. Formula (I) is shown below:

INHIBITORS OF AKT ACTIVITY

The invention relates to a series of compounds with particular activity as inhibitors of the serine-threonine kinase AKT. Also provided are pharmaceutical compositions comprising same as well as methods for treating cancer.